Study to Identify Factors associated with Resilience to Clinical Dementia at Old Age Studie naar de beschermende factoren voor dementie bij mensen boven de 90 jaar

Trial Profile

Study to Identify Factors associated with Resilience to Clinical Dementia at Old Age Studie naar de beschermende factoren voor dementie bij mensen boven de 90 jaar

Recruiting
Phase of Trial: Phase III

Latest Information Update: 30 May 2018

At a glance

  • Drugs Flutemetamol-F-18 (Primary)
  • Indications Alzheimer's disease
  • Focus Biomarker; Diagnostic use
  • Acronyms 90+ Study
  • Most Recent Events

    • 02 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top